GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Volatility

Tissue Regenix Group (LSE:TRX) Volatility : 34.07% (As of May. 21, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2024-05-21), Tissue Regenix Group's Volatility is 34.07%.


Competitive Comparison of Tissue Regenix Group's Volatility

For the Biotechnology subindustry, Tissue Regenix Group's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tissue Regenix Group's Volatility Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Volatility distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Volatility falls into.



Tissue Regenix Group  (LSE:TRX) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tissue Regenix Group  (LSE:TRX) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Tissue Regenix Group Volatility Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


Tissue Regenix Group (LSE:TRX) Business Description

Traded in Other Exchanges
Address
Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.

Tissue Regenix Group (LSE:TRX) Headlines

From GuruFocus

Doubling of Gold Mineral Resources Confirmed

By GlobeNewswire GlobeNewswire 06-23-2020

Tanzanian Gold Clarifies Disclosure

By GlobeNewswire GlobeNewswire 02-21-2020

Tanzanian Royalty Reports Annual Meeting Voting Results

By GlobeNewswire GlobeNewswire 03-23-2019

Buckreef Gold Mine Development Update

By GlobeNewswire GlobeNewswire 09-12-2019

Tanzanian Gold Corporation Announces Public Offering of Common Shares

By GlobeNewswire GlobeNewswire 12-16-2019